Advertisement
Screener

Panacea Life Sciences Holdings, Inc. (PLSH) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

1.7 / 5 stars · 12/36 Roast Me

Panacea Life Sciences Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

Panacea Life Sciences Holdings, Inc. (PLSH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 1.90 million shares for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-04-23.

Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2021-04-23

  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-12-31 was 29.95K shares, a 95.21% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-09-30 was 980.00K shares.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-06-30 was 28.13K shares.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-03-31 was 861.46K shares.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 1.90M shares, a 184.93% increase from fiscal 2019.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 666.67K shares.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 0.00 shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month
2020-12-3129.95K shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23
1.01M shares
derived: sum of 2 quarters · filed 2021-04-23
1.04M shares
derived: sum of 3 quarters · filed 2021-04-23
1.90M shares
10-K/A · filed 2021-04-23
2020-09-30980.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-18
1.01M shares
derived: sum of 2 quarters · filed 2020-11-18
1.87M shares
10-Q · filed 2020-11-18
2.49M shares
derived: sum of 4 quarters · filed 2021-04-23
2020-06-3028.13K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19
889.58K shares
10-Q · filed 2020-08-19
1.51M shares
derived: sum of 3 quarters · filed 2021-04-23
2020-03-31861.46K shares
10-Q · filed 2020-06-29
1.49M shares
derived: sum of 2 quarters · filed 2021-04-23
2019-12-31625.00K shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23
666.67K shares
10-K/A · filed 2021-04-23
2019-09-3041.67K shares
10-Q · filed 2019-11-14
2018-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-22
0.00 shares
10-K · filed 2020-05-22
2018-09-300.00 shares
10-Q · filed 2018-11-14